SEC Form 4 · accession 0001209191-16-144286
IMMUNE DESIGN CORP. · IMDZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sergey Yurasov
Officer — Sr. VP, Clinic. Devel. & CMO
Period of report
Oct 1, 2016
Accepted (ET)
Oct 4, 2016 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437786
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $7.58 | Oct 1, 2016 | A | 140,000 | A | — | Oct 1, 2026 | Common Stock | 140,000 | 140,000 | D |
Explanation of responses
- F1One quarter of the shares underlying the option will vest on October 1, 2017, and the remainder of the shares underlying the option will vest monthly in equal installments at a rate of 1/36th per month thereafter, subject to the Reporting Person's continuous service through each such date.